Lengauer, H.; Makuc, D.; Šterk, D.; Perdih, F.; Pichler, A.; Trdan Lušin, T.; Plavec, J.; Časar, Z.
Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates. Pharmaceutics 2020, 12, 342.
https://doi.org/10.3390/pharmaceutics12040342
AMA Style
Lengauer H, Makuc D, Šterk D, Perdih F, Pichler A, Trdan Lušin T, Plavec J, Časar Z.
Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates. Pharmaceutics. 2020; 12(4):342.
https://doi.org/10.3390/pharmaceutics12040342
Chicago/Turabian Style
Lengauer, Hannes, Damjan Makuc, Damjan Šterk, Franc Perdih, Arthur Pichler, Tina Trdan Lušin, Janez Plavec, and Zdenko Časar.
2020. "Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates" Pharmaceutics 12, no. 4: 342.
https://doi.org/10.3390/pharmaceutics12040342
APA Style
Lengauer, H., Makuc, D., Šterk, D., Perdih, F., Pichler, A., Trdan Lušin, T., Plavec, J., & Časar, Z.
(2020). Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates. Pharmaceutics, 12(4), 342.
https://doi.org/10.3390/pharmaceutics12040342